Ashkenazi S - Search Results

1

Immune status against diphtheria among immigrants from the former USSR who arrived in Israel during 1990-1991.

Low M, Almog R, Green MS, Ashkenazi S, Bercovier H, Katzenelson E, Ashkenazi I, Shemer J, Cohen D. Low M, et al. Among authors: ashkenazi i, ashkenazi s. Infection. 1998 Mar-Apr;26(2):104-8. doi: 10.1007/BF02767769. Infection. 1998. PMID: 9561380

2

Transient anti-hepatitis C antibodies after influenza vaccination.

Bar-Shany S, Gilon E, Almog R, Ashkenazi S. Bar-Shany S, et al. Among authors: ashkenazi s. Infection. 1994 Sep-Oct;22(5):367. doi: 10.1007/BF01715554. Infection. 1994. PMID: 7531182 No abstract available.

3

Safety and immunogenicity of the oral E. coli K12-S. flexneri 2a vaccine (EcSf2a-2) among Israeli soldiers.

Cohen D, Ashkenazi S, Green MS, Yavzori M, Orr N, Slepon R, Lerman Y, Robin G, Ambar R, Block C, et al. Cohen D, et al. Among authors: ashkenazi s. Vaccine. 1994 Nov;12(15):1436-42. doi: 10.1016/0264-410x(94)90153-8. Vaccine. 1994. PMID: 7887022 Clinical Trial.

4

An update on Shigella vaccines.

Ashkenazi S, Cohen D. Ashkenazi S, et al. Isr J Med Sci. 1994 May-Jun;30(5-6):495-7. Isr J Med Sci. 1994. PMID: 8034510 Review.

5

Identification of Shigella species in stool specimens by DNA amplification of different loci of the Shigella virulence plasmid.

Yavzori M, Cohen D, Wasserlauf R, Ambar R, Rechavi G, Ashkenazi S. Yavzori M, et al. Among authors: ashkenazi s. Eur J Clin Microbiol Infect Dis. 1994 Mar;13(3):232-7. doi: 10.1007/BF01974542. Eur J Clin Microbiol Infect Dis. 1994. PMID: 8050436

6

First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin.

Almog R, Block C, Gdalevich M, Lev B, Wiener M, Ashkenazi S. Almog R, et al. Among authors: ashkenazi s. Infection. 1994 Mar-Apr;22(2):69-71. doi: 10.1007/BF01739006. Infection. 1994. PMID: 8070932

7

Four-year follow-up of the immune status of young adults given a single booster dose of trivalent oral poliovaccine.

Green MS, Handsher R, Slepon R, Ashkenazi S, Mendelson E, Cohen D. Green MS, et al. Among authors: ashkenazi s. Vaccine. 1994 May;12(7):582-4. doi: 10.1016/0264-410x(94)90260-7. Vaccine. 1994. PMID: 8085373

8

Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: a three-year prospective study.

Lerman Y, Shohat T, Ashkenazi S, Almog R, Heering SL, Shemer J. Lerman Y, et al. Among authors: ashkenazi s. Clin Infect Dis. 1993 Sep;17(3):411-4. doi: 10.1093/clinids/17.3.411. Clin Infect Dis. 1993. PMID: 8218682 Clinical Trial.

9

Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.

Taylor DN, Trofa AC, Sadoff J, Chu C, Bryla D, Shiloach J, Cohen D, Ashkenazi S, Lerman Y, Egan W, et al. Taylor DN, et al. Among authors: ashkenazi s. Infect Immun. 1993 Sep;61(9):3678-87. doi: 10.1128/iai.61.9.3678-3687.1993. Infect Immun. 1993. PMID: 8359890 Free PMC article.

10

Clinical trials of Shigella vaccines in Israel.

Cohen D, Ashkenazi S, Green M, Gdalevich M, Yavzori M, Orr N, Robin G, Slepon R, Lerman Y, Block C, Ashkenazi I, Taylor D, Hale L, Sadoff J, Schneerson R, Robbins J, Wiener M, Shemer J. Cohen D, et al. Among authors: ashkenazi i, ashkenazi s. Adv Exp Med Biol. 1996;397:159-67. doi: 10.1007/978-1-4899-1382-1_21. Adv Exp Med Biol. 1996. PMID: 8718595 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters